Live Breaking News & Updates on Opplian Pharma

Stay updated with breaking news from Opplian pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Meta-Analysis Favors SubQ Infliximab Over Vedolizumab in Crohn's

Researchers evaluated results of seven major studies to compare efficacy and safety of the two agents in Crohn s disease and ulcerative colitis. ....

City Of , United Kingdom , Opplian Pharma , Laurent Peyrin Biroulet , Samsung Bioepis , Fresenius Kabi , Bristol Myers Squibb , Mark Samaan , Colitis Organisation , Drug Administration , European Medicines Agency , University Hospital Of Nancy , European Crohn , University Hospital , Disease Activity , Sublimity Therapeutics , Applied Molecular Transport , Inflammatory Bowel Disease , Nflammatory Bowel Disease Ibd , Crohns Disease , Ulcerative Colitis , Anti Tnf , Anti Tumor Necrosis Factor , Biologic Therapy , Biosimilar Drugs , Follow On Biologics ,